Skip to main content
. Author manuscript; available in PMC: 2008 Feb 1.
Published in final edited form as: Cardiovasc Res. 2006 Nov 30;73(3):549–559. doi: 10.1016/j.cardiores.2006.11.031

Fig. 4.

Fig. 4

Effects of CeO2 nanoparticles on MCP-1 expression and release. (A) Immunoblot showing levels of MCP-1 in the myocardium of wild-type control, vehicle-, and CeO2-treated MCP mice. (B) Summary of densitometric analysis of data in A. *P < 0.001 versus wild-type control; #P<0.05 versus vehicle-treated MCP mice and wild-type controls; n=5 per group. (C–D) Circulating levels of MCP-1 and CRP assayed by ELISA. *P < 0.001 versus wild-type control; #P<0.05 versus vehicle-treated MCP mice and wild-type controls; n=6 per group.